Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PA) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Global Medical REIT (GMRE-PA) over the last 10 years, with Q3 2025 value amounting to -$6.0 million.

  • Global Medical REIT's Net Income towards Common Stockholders fell 43506.42% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year decrease of 13701.85%. This contributed to the annual value of $811000.0 for FY2024, which is 9451.66% down from last year.
  • As of Q3 2025, Global Medical REIT's Net Income towards Common Stockholders stood at -$6.0 million, which was down 43506.42% from -$800000.0 recorded in Q2 2025.
  • Global Medical REIT's Net Income towards Common Stockholders' 5-year high stood at $11.8 million during Q2 2023, with a 5-year trough of -$6.0 million in Q3 2025.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $1.8 million (2024), whereas its average is $1.9 million.
  • As far as peak fluctuations go, Global Medical REIT's Net Income towards Common Stockholders soared by 115147.06% in 2021, and later plummeted by 43506.42% in 2025.
  • Quarter analysis of 5 years shows Global Medical REIT's Net Income towards Common Stockholders stood at $3.8 million in 2021, then tumbled by 90.32% to $368000.0 in 2022, then crashed by 328.26% to -$840000.0 in 2023, then skyrocketed by 263.57% to $1.4 million in 2024, then plummeted by 536.75% to -$6.0 million in 2025.
  • Its last three reported values are -$6.0 million in Q3 2025, -$800000.0 for Q2 2025, and $2.1 million during Q1 2025.